Your browser does not support iframes.
N&O 100
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Anika Therapeutics, Inc.
(NQ:
ANIK
)
17.55
USD
UNCHANGED
Streaming Delayed Price
/ Updated:
12:52 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
91,944
Open
17.72
Bid (Size)
17.49 (200)
Ask (Size)
17.55 (100)
Prev. Close
17.55
Today's Range
17.00 - 18.07
52wk Range
9.130 - 16.89
Shares Outstanding
13,996,250
Dividend Yield
N/A
Top News
More News
18.4% Return Seen to Date on SmarTrend Anika Therapeutics Call (ANIK)
Today 10:41 EDT
from
Comtex SmarTrend® News Briefs
Anika Therapeutics: 52-Week High Recently Eclipsed (ANIK)
June 18, 2013
from
Comtex SmarTrend® News Briefs
More News
Read More
Anika Therapeutics Reports First-Quarter 2013 Financial Results
May 01, 2013
from
Business Wire News Releases
Anika Therapeutics Announces Date of First-Quarter 2013 Financial Results Conference Call
April 05, 2013
from
Business Wire News Releases
Anika Therapeutics to Present at the Canaccord Genuity Musculoskeletal Conference on March 19
March 13, 2013
from
Business Wire News Releases
The Prescription of Success: Improving Pipelines, Increasing Capabilities - Research Report on Globus, Akorn, Anika, Orthofix and Sangamo Biosciences
March 05, 2013
from
PR Newswire
Free Research Reports on ANAC, ANIK, OREX and PANL Issued by the Bedford Report
March 01, 2013
from
Marketwired News Releases
Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High
March 01, 2013
from
Marketwired News Releases
Ubika Research’s Daily US Box Score: Top Junior Technology (NASDAQ: RNIN) Stock Gained 109%
February 28, 2013
from
ACCESSWIRE
Ubika Research’s Daily US Box Score: Top Junior Technology (NASDAQ: RNIN) Stock Gained 109%
February 28, 2013
from
ACCESSWIRE
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.